259 related articles for article (PubMed ID: 14534709)
1. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R
Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709
[TBL] [Abstract][Full Text] [Related]
2. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
[TBL] [Abstract][Full Text] [Related]
3. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
4. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages.
Kuniyasu H; Yano S; Sasaki T; Sasahira T; Sone S; Ohmori H
Am J Pathol; 2005 Mar; 166(3):751-60. PubMed ID: 15743787
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
Kuniyasu H; Chihara Y; Takahashi T
Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
[TBL] [Abstract][Full Text] [Related]
6. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
8. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
Allmen EU; Koch M; Fritz G; Legler DF
Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
[TBL] [Abstract][Full Text] [Related]
9. Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer.
Kuniyasu H; Sasaki T; Sasahira T; Ohmori H; Takahashi T
Pathobiology; 2004; 71(3):129-36. PubMed ID: 15051925
[TBL] [Abstract][Full Text] [Related]
10. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
12. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
[TBL] [Abstract][Full Text] [Related]
13. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy.
Kruithof-Dekker IG; Têtu B; Janssen PJ; Van der Kwast TH
J Urol; 1996 Sep; 156(3):1194-7. PubMed ID: 8709345
[TBL] [Abstract][Full Text] [Related]
14. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
[TBL] [Abstract][Full Text] [Related]
15. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
16. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
17. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
18. Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression.
Azoulay S; Terry S; Chimingqi M; Sirab N; Faucon H; Gil Diez de Medina S; Moutereau S; Maillé P; Soyeux P; Abbou C; Salomon L; Vacherot F; de La Taille A; Loric S; Allory Y
J Pathol; 2008 Dec; 216(4):460-70. PubMed ID: 18825689
[TBL] [Abstract][Full Text] [Related]
19. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Taguchi A; Blood DC; del Toro G; Canet A; Lee DC; Qu W; Tanji N; Lu Y; Lalla E; Fu C; Hofmann MA; Kislinger T; Ingram M; Lu A; Tanaka H; Hori O; Ogawa S; Stern DM; Schmidt AM
Nature; 2000 May; 405(6784):354-60. PubMed ID: 10830965
[TBL] [Abstract][Full Text] [Related]
20. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
